Daiwa Securities Group Inc. Aurinia Pharmaceuticals Inc. Transaction History
Daiwa Securities Group Inc.
- $18.8 Billion
- Q2 2024
A detailed history of Daiwa Securities Group Inc. transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 528 shares of AUPH stock, worth $3,843. This represents 0.0% of its overall portfolio holdings.
Number of Shares
528
Previous 528
-0.0%
Holding current value
$3,843
Previous $3,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding AUPH
# of Institutions
191Shares Held
56.2MCall Options Held
499KPut Options Held
637K-
Armistice Capital, LLC New York, NY11.1MShares$81.1 Million0.83% of portfolio
-
Black Rock Inc. New York, NY9.27MShares$67.5 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$28.9 Million2.14% of portfolio
-
State Street Corp Boston, MA2.88MShares$21 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.78MShares$20.2 Million1.94% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.03B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...